-
Pliant Therapeutics (NASDAQ:PLRX) Downgraded to "Neutral" Rating by JPMorgan Chase & Co.
Source: Buzz FX / 10 Feb 2025 09:31:10 America/New_York
Pliant Therapeutics (NASDAQ:PLRX) Downgraded to "Neutral" Rating by JPMorgan Chase & Co. Written by MarketBeat February 10, 2025 Share Link copied to clipboard. Pliant Therapeutics ( NASDAQ:PLRX - Get Free Report ) was downgraded by JPMorga
Read more...